PD-L1 Antikörper (AA 34-241)
Kurzübersicht für PD-L1 Antikörper (AA 34-241) (ABIN7428623)
Target
Alle PD-L1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 34-241
-
Verwendungszweck
- Monoclonal Antibody to Programmed Cell Death Protein 1 Ligand 1 (PDL1)
-
Spezifität
- The antibody is a mouse monoclonal antibody raised against PDL1. It has been selected for its ability to recognize PDL1 in immunohistochemical staining and western blotting.
-
Aufreinigung
- Protein A + Protein G affinity chromatography
-
Immunogen
- Recombinant Programmed Cell Death Protein 1 Ligand 1 (PDL1) corresdonding to Ser34~Val241 with N-terminal His and GST Tag
-
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
- Western blotting: 0.5-2 μg/mL,1:500-2000,Immunohistochemistry: 5-20 μg/mL,1:50-200,Immunocytochemistry: 5-20 μg/mL,1:50-200,Optimal working dilutions must be determined by end user.
-
Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 24 months
-
-
- PD-L1 (CD274 (PD-L1))
-
Andere Bezeichnung
- PDL1
-
Hintergrund
- CD274, PDCD1LG1, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1-LG1, Programed Death Ligand 1
-
UniProt
- D4AE25
-
Pathways
- Cancer Immune Checkpoints
Target
-